Takeda, Crescendo Biologics in Therapeutics Pact Worth Up to $790 Million
By
Takeda Pharmaceutical Company has formed a collaboration with Crescendo Biologics Limited, a Cambridge, UK-based biopharmaceutical company, to discover, develop, and commercialize Humabody-based cancer therapeutics in a deal worth up to…